Some things remain the same for Bausch + Lomb Corp., with its consumer health eye health and vision care products its largest sales driver in the fourth quarter and throughout 2022, while a change will come to CEO post in two weeks.
B+L’s consumer portfolio “continued its market leadership position with momentum in our strategic brands,” said chief financial officer Sam Eldessouky...







